NCR Online Journal

Press Release

Rheumatoid Arthritis Market to Witness Upsurge in Growth During the Forecast Period (2024-2034), Examines DelveInsight | AbbVie, Pfizer, Regeneron/Sanofi, Eli Lilly and Company, UCB BIOSCIENCES GmbH

The Rheumatoid Arthritis market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Rheumatoid Arthritis pipeline products will significantly

Read Full Article

Myopia Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | ALCON, Bausch Health , Essilor Luxottica (Essilor Ltd), Johnson & Johnson

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myopia pipeline constitutes 7+ key companies continuously working towards developing 8+ Myopia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism

Read Full Article

Obstructive Sleep Apnea Market to Observe Impressive Growth During the Forecast Period (2023-2032), Evaluates DelveInsight | Apnimed, Taisho Pharma, Takeda, Bayer, Eli Lilly and Company, Axsome

The Obstructive Sleep Apnea Market size was valued approximately USD 408 million in 2022 and the report offers an in-depth understanding of the Obstructive Sleep Apnea, historical and forecasted epidemiology

Read Full Article

Idiopathic Pulmonary Fibrosis Pipeline Assessment | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Aria Pharmaceuticals

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Idiopathic Pulmonary Fibrosis pipeline constitutes 80+ key companies continuously working towards developing 100+ Idiopathic Pulmonary Fibrosis treatment therapies, analysis of

Read Full Article

Peripheral Artery Disease Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest Drug Approvals by DelveInsight | Humacyte, Inc., Novo Nordisk, Helixmith, Ixaka Ltd, Hemostemix, Caladrius

The Peripheral Artery Disease Market Forecast report offers an in-depth understanding of the Peripheral Artery Disease, historical and forecasted epidemiology

Read Full Article

Solid Biomass Feedstock Market worth $36.2 Billion by 2029

The global solid biomass feedstock market is expected to grow from an estimated USD 26.6 billion in 2024 to USD

Read Full Article

Non-Cystic Fibrosis Bronchiectasis Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Insmed Inc, AstraZeneca, Zambon, CSL Behring

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Non-Cystic Fibrosis Bronchiectasis pipeline constitutes 16+ key companies continuously working

Read Full Article

Cervical Dystonia Market Report 2034: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | AEON Biopharma, Daewoong Pharmaceuticals, Revance Therapeutics

The Cervical Dystonia Market size was valued approximately USD 303 million in 2022 and the report offers an in-depth understanding

Read Full Article

Bronchiolitis Obliterans Syndrome Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Renovion, Inc., Zambon SpA, Incyte Corp., Chia Tai Tianqing

The Bronchiolitis Obliterans Syndrome Market size was valued approximately USD 58 Million in 2022 and the report offers an in-depth

Read Full Article

Spinal Muscular Atrophy Pipeline Drugs Analysis Report, 2024 Updates: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Genentech Inc, Chugai Pharma, Cytokinetics Inc, Ionis Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Spinal Muscular Atrophy pipeline constitutes 18+ key companies continuously working

Read Full Article